Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53

Oncogene

Volumn 18, Issue 51, 1999, Pages 7310-7318

  Kim, Ella ^a   Rohaly, Gabor ^a   Heinrichs, Stefan ^a   Gimnopoulos, Dimitri ^a   Meißner, Hildegard ^b   Deppert, Wolfgang ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

DNA conformationl; mdm2; Non B DNA; p53; Sequence specific DNA binding; Transcriptional activation

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA CONFORMATION; DNA SEQUENCE; DNA SUPERCOILING; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PROCESSING; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

EID: 0033518119     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203139     Document Type: Article

References (31)

1. Anker L, Ohgaki H, Ludeke BI, Herrmann HD, Kleihues P and Westphal M. (1993). Int. J. Cancer, 55, 982-987.
2. Arriola EL, Lopez AR and Chresta CM. (1999). Oncogene, 18, 1081-1091.
3. Barak Y, Juven T, Haffner R and Oren M. (1993). EMBO J., 12, 461-468.
4. Chin PL, Momand J and Pfeifer GP. (1997). Oncogene, 15, 87-99.
5. Di Como CJ and Prives C. (1998). Oncogene, 16, 2527-2539.
6. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
7. Garcia JF, Piris MA, Lloret E, Orradre JL, Murillo PG and Martinez J. (1997). Histopathology, 30, 120-125.
8. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM and Gudkov AV. (1998). Nature, 391, 295-298.
9. Gellert M, O'Dea MH and Mizuuchi K. (1983). Proc. Natl. Acad. Sci. USA, 80, 5545-5549.
10. Gobert C, Bracco L, Rossi F, Olivier M, Tazi J, Lavelle F, Larsen AK and Riou JF. (1996). Biochemistry, 35, 5778-5786.
11. Gu W and Roeder RG. (1997). Cell, 90, 595-606.
12. Hupp TR, Meek DW, Midgley CA and Lane DP. (1992). Cell, 71, 875-886.
13. Jayaraman L and Prives C. (1995). Cell, 81, 1021-1029.
14. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S and Prives C. (1997). Genes Dev., 11, 558-570.
15. Jayaraman L, Moorthy NC, Murthy KGK, Manley JL, Bustin M and Prives C. (1998). Genes Dev., 12, 462-472.
16. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C and Vogelstein B. (1991). Science, 252, 1708-1711.
17. Kim E, Albrechtsen N and Deppert W. (1997). Oncogene, 15, 857-869.
18. Lill NL, Grossman SR, Ginsberg D, DeCaprio J and Livingston DM. (1997). Nature, 387, 823-827.
19. Luna RMD, Amelse LL, Chavez-Reyes A, Evans SC, Brugarolas J, Jacks T and Lozano G. (1997). Nature Genet, 16, 336-337.
20. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T. (1995). Genes Dev., 9, 935-944.
21. Mummenbrauer T, Janus F, Mueller B, Wiesmueller L, Deppert W and Grosse F. (1996). Cell, 85, 1089-1099.
22. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M and Vousden KH. (1996). EMBO J., 15, 827-838.
23. Saucedo LJ, Carstens BP, Seavey SE, Albee II LD and Perry ME. (1998). Cell Growth Differ., 9, 119-130.
24. Shaw P, Freeman J, Bovey R and Iggo R. (1996). Oncogene, 12, 921-930.
25. Sinden RR, Broyles SS and Pettijohn DE. (1983). Proc. Natl. Acad. Sci. USA, 80, 1797-1801.
26. Wang X and Ohnishi T. (1997). J. Radiat. Res., 38, 179-194.
27. Wang Y and Prives C. (1995). Nature, 376, 88-91.
28. Wu X, Bayle JH, Olson D and Levine AJ. (1993). Genes Dev., 7, 1126-2232.
29. Xiao G, White D and Bargonetti J. (1998). Oncogene, 16, 1171-1181.
30. Yagil G. (1991). Crit. Rev. Biochem. Mol. Biol., 26, 475-559.
31. Zauberman A, Flusberg D, Haupt Y, Barak Y and Oren M. (1995). Nucleic Acids Res., 23, 2584-2592.